135 related articles for article (PubMed ID: 35587449)
21. Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome.
Kim KH; Park SW; Kim MK; Wee WR
Korean J Ophthalmol; 2013 Oct; 27(5):331-40. PubMed ID: 24082770
[TBL] [Abstract][Full Text] [Related]
22. Sutureless Amniotic Membrane Transplantation Using Pediatric Nasogastric Tube for Patients With Acute Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Ceylan A; Mergen B; Aydin FO; Avci E; Yildirim Y
Eye Contact Lens; 2023 May; 49(5):199-203. PubMed ID: 36943174
[TBL] [Abstract][Full Text] [Related]
23. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Sotozono C; Ueta M; Nakatani E; Kitami A; Watanabe H; Sueki H; Iijima M; Aihara M; Ikezawa Z; Aihara Y; Kano Y; Shiohara T; Tohyama M; Shirakata Y; Kaneda H; Fukushima M; Kinoshita S; Hashimoto K;
Am J Ophthalmol; 2015 Aug; 160(2):228-237.e2. PubMed ID: 25979679
[TBL] [Abstract][Full Text] [Related]
24. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Sato S; Kanbe T; Tamaki Z; Furuichi M; Uejima Y; Suganuma E; Takano T; Kawano Y
Pediatr Int; 2018 Aug; 60(8):697-702. PubMed ID: 29888432
[TBL] [Abstract][Full Text] [Related]
25. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications.
Ueta M
Cornea; 2015 Nov; 34 Suppl 11():S158-65. PubMed ID: 26448174
[TBL] [Abstract][Full Text] [Related]
26. [
Gao TT; Li Y; Liu J; Long Q
Zhonghua Yan Ke Za Zhi; 2017 Mar; 53(3):177-181. PubMed ID: 28316191
[No Abstract] [Full Text] [Related]
27. Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.
Shanbhag SS; Hall L; Chodosh J; Saeed HN
Ocul Surf; 2020 Jul; 18(3):517-522. PubMed ID: 32200005
[TBL] [Abstract][Full Text] [Related]
28. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
29. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
[TBL] [Abstract][Full Text] [Related]
30. Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.
Ma DH; Tsai TY; Pan LY; Chen SY; Hsiao CH; Yeh LK; Tan HY; Lu CW; Chen CB; Chung WH
Front Med (Lausanne); 2021; 8():661891. PubMed ID: 34055837
[No Abstract] [Full Text] [Related]
31. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
[TBL] [Abstract][Full Text] [Related]
32. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ
Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
[TBL] [Abstract][Full Text] [Related]
33. [Ophthalmic manifestations after Lyell and Stevens-Johnson syndromes].
Mouafik SB; Hocar O; Akhdari N; Amal S; Belghmaidi S; Ennassiri W; Hajji I; Moutaouakil A
Ann Dermatol Venereol; 2015; 142(6-7):393-8. PubMed ID: 25896732
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
[TBL] [Abstract][Full Text] [Related]
35. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
[TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
37. Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Saito K; Ueta M; Maekawa K; Sotozono C; Kinoshita S; Saito Y
PLoS One; 2016; 11(11):e0167402. PubMed ID: 27898730
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Ocular Manifestation and Genetic Association of Allopurinol-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in South Korea.
Lee HS; Ueta M; Kim MK; Seo KY; Sotozono C; Kinoshita S; Yoon KC
Cornea; 2016 Feb; 35(2):199-204. PubMed ID: 26655481
[TBL] [Abstract][Full Text] [Related]
39. Corneal Limbal Stem Cell Deficiency in Children with Stevens-Johnson Syndrome.
Choi SH; Kim MK; Oh JY
Am J Ophthalmol; 2019 Mar; 199():1-8. PubMed ID: 30347185
[TBL] [Abstract][Full Text] [Related]
40. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
